目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. INFECTIOUS DISEASE DRUG MARKET, BY DRUG TYPE (USD BILLION)
6.1. Antibiotics
6.2. Antivirals
6.3. Antifungals
6.4. Antiparasitics

7. INFECTIOUS DISEASE DRUG MARKET, BY ROUTE OF ADMINISTRATION (USD BILLION)
7.1. Oral
7.2. Injectable
7.3. Topical
7.4. Inhalation

8. INFECTIOUS DISEASE DRUG MARKET, BY THERAPEUTIC AREA (USD BILLION)
8.1. Bacterial Infections
8.2. Viral Infections
8.3. Fungal Infections
8.4. Parasitic Infections

9. INFECTIOUS DISEASE DRUG MARKET, BY DISTRIBUTION CHANNEL (USD BILLION)
9.1. Hospital Pharmacies
9.2. Retail Pharmacies
9.3. Online Pharmacies

10. INFECTIOUS DISEASE DRUG MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA

11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Infectious Disease Drug Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Infectious Disease Drug Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES
12.1. Roche
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Regeneron Pharmaceuticals
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Amgen
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Johnson and Johnson
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Merck and Co
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Pfizer
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Eli Lilly
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. BristolMyers Squibb
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. GlaxoSmithKline
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. AbbVie
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Sanofi
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Takeda Pharmaceutical
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Novartis
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. AstraZeneca
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Gilead Sciences
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies

13. APPENDIX
13.1. References
13.2. Related Reports

LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 3. NORTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 4. NORTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 5. NORTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 6. NORTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 7. US INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 8. US INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 9. US INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 10. US INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 11. US INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 12. CANADA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 13. CANADA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 14. CANADA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 15. CANADA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 16. CANADA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 17. EUROPE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 18. EUROPE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 19. EUROPE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 20. EUROPE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 21. EUROPE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 22. GERMANY INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 23. GERMANY INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 24. GERMANY INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 25. GERMANY INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 26. GERMANY INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 27. UK INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 28. UK INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 29. UK INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 30. UK INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 31. UK INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 32. FRANCE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 33. FRANCE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 34. FRANCE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 35. FRANCE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 36. FRANCE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 37. RUSSIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 38. RUSSIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 39. RUSSIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 40. RUSSIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 41. RUSSIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 42. ITALY INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 43. ITALY INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 44. ITALY INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 45. ITALY INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 46. ITALY INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 47. SPAIN INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 48. SPAIN INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 49. SPAIN INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 50. SPAIN INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 51. SPAIN INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 52. REST OF EUROPE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 53. REST OF EUROPE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 54. REST OF EUROPE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 55. REST OF EUROPE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 56. REST OF EUROPE INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 57. APAC INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 58. APAC INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 59. APAC INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 60. APAC INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 61. APAC INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 62. CHINA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 63. CHINA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 64. CHINA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 65. CHINA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 66. CHINA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 67. INDIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 68. INDIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 69. INDIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 70. INDIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 71. INDIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 72. JAPAN INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 73. JAPAN INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 74. JAPAN INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 75. JAPAN INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 76. JAPAN INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 77. SOUTH KOREA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 78. SOUTH KOREA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 79. SOUTH KOREA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 80. SOUTH KOREA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 81. SOUTH KOREA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 82. MALAYSIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 83. MALAYSIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 84. MALAYSIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 85. MALAYSIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 86. MALAYSIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 87. THAILAND INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 88. THAILAND INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 89. THAILAND INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 90. THAILAND INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 91. THAILAND INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 92. INDONESIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 93. INDONESIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 94. INDONESIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 95. INDONESIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 96. INDONESIA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 97. REST OF APAC INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 98. REST OF APAC INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 99. REST OF APAC INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 100. REST OF APAC INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 101. REST OF APAC INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 102. SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 103. SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 104. SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 105. SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 106. SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 107. BRAZIL INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 108. BRAZIL INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 109. BRAZIL INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 110. BRAZIL INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 111. BRAZIL INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 112. MEXICO INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 113. MEXICO INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 114. MEXICO INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 115. MEXICO INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 116. MEXICO INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 117. ARGENTINA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 118. ARGENTINA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 119. ARGENTINA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 120. ARGENTINA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 121. ARGENTINA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 127. MEA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 128. MEA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 129. MEA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 130. MEA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 131. MEA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 132. GCC COUNTRIES INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 133. GCC COUNTRIES INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 134. GCC COUNTRIES INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 135. GCC COUNTRIES INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 136. GCC COUNTRIES INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 137. SOUTH AFRICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 138. SOUTH AFRICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 139. SOUTH AFRICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 140. SOUTH AFRICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 141. SOUTH AFRICA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 142. REST OF MEA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD BILLIONS)
TABLE 143. REST OF MEA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD BILLIONS)
TABLE 144. REST OF MEA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
TABLE 145. REST OF MEA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS)
TABLE 146. REST OF MEA INFECTIOUS DISEASE DRUG MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP

LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA INFECTIOUS DISEASE DRUG MARKET ANALYSIS
FIGURE 3. US INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 4. US INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 5. US INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 6. US INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 7. US INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 9. CANADA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 10. CANADA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 11. CANADA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 12. CANADA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE INFECTIOUS DISEASE DRUG MARKET ANALYSIS
FIGURE 14. GERMANY INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 15. GERMANY INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 16. GERMANY INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 17. GERMANY INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 18. GERMANY INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 20. UK INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 21. UK INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 22. UK INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 23. UK INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 25. FRANCE INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 26. FRANCE INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 27. FRANCE INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 28. FRANCE INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 30. RUSSIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 31. RUSSIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 32. RUSSIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 33. RUSSIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 35. ITALY INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 36. ITALY INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 37. ITALY INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 38. ITALY INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 40. SPAIN INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 41. SPAIN INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 42. SPAIN INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 43. SPAIN INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 45. REST OF EUROPE INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 46. REST OF EUROPE INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 47. REST OF EUROPE INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 48. REST OF EUROPE INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC INFECTIOUS DISEASE DRUG MARKET ANALYSIS
FIGURE 50. CHINA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 51. CHINA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 52. CHINA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 53. CHINA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 54. CHINA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 56. INDIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 57. INDIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 58. INDIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 59. INDIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 61. JAPAN INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 62. JAPAN INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 63. JAPAN INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 64. JAPAN INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 66. SOUTH KOREA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 67. SOUTH KOREA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 68. SOUTH KOREA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 69. SOUTH KOREA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 71. MALAYSIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 72. MALAYSIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 73. MALAYSIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 74. MALAYSIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 76. THAILAND INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 77. THAILAND INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 78. THAILAND INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 79. THAILAND INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 81. INDONESIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 82. INDONESIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 83. INDONESIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 84. INDONESIA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 86. REST OF APAC INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 87. REST OF APAC INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 88. REST OF APAC INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 89. REST OF APAC INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET ANALYSIS
FIGURE 91. BRAZIL INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 92. BRAZIL INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 93. BRAZIL INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 94. BRAZIL INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 95. BRAZIL INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 97. MEXICO INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 98. MEXICO INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 99. MEXICO INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 100. MEXICO INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 102. ARGENTINA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 103. ARGENTINA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 104. ARGENTINA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 105. ARGENTINA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 107. REST OF SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 108. REST OF SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 109. REST OF SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 110. REST OF SOUTH AMERICA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA INFECTIOUS DISEASE DRUG MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 113. GCC COUNTRIES INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 114. GCC COUNTRIES INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 115. GCC COUNTRIES INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 116. GCC COUNTRIES INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 118. SOUTH AFRICA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 119. SOUTH AFRICA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 120. SOUTH AFRICA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 121. SOUTH AFRICA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DRUG TYPE
FIGURE 123. REST OF MEA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
FIGURE 124. REST OF MEA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY THERAPEUTIC AREA
FIGURE 125. REST OF MEA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 126. REST OF MEA INFECTIOUS DISEASE DRUG MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF INFECTIOUS DISEASE DRUG MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF INFECTIOUS DISEASE DRUG MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: INFECTIOUS DISEASE DRUG MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: INFECTIOUS DISEASE DRUG MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: INFECTIOUS DISEASE DRUG MARKET
FIGURE 133. INFECTIOUS DISEASE DRUG MARKET, BY DRUG TYPE, 2024 (% SHARE)
FIGURE 134. INFECTIOUS DISEASE DRUG MARKET, BY DRUG TYPE, 2019 TO 2035 (USD Billions)
FIGURE 135. INFECTIOUS DISEASE DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
FIGURE 136. INFECTIOUS DISEASE DRUG MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2035 (USD Billions)
FIGURE 137. INFECTIOUS DISEASE DRUG MARKET, BY THERAPEUTIC AREA, 2024 (% SHARE)
FIGURE 138. INFECTIOUS DISEASE DRUG MARKET, BY THERAPEUTIC AREA, 2019 TO 2035 (USD Billions)
FIGURE 139. INFECTIOUS DISEASE DRUG MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
FIGURE 140. INFECTIOUS DISEASE DRUG MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2035 (USD Billions)
FIGURE 141. INFECTIOUS DISEASE DRUG MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. INFECTIOUS DISEASE DRUG MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS